International Patent: 4'-SPIRO-MODIFIED THREOSE NUCLEOSIDE PHOSPHORAMIDITE COMPOUND AND USE IN OLIGONUCLEOTIDES

GENEVA, July 1 -- LEADERNA THERAPEUTICS, LTD. filed a patent application (CN2025/142435) for “4'-SPIRO-MODIFIED THREOSE NUCLEOSIDE PHOSPHORAMIDITE COMPOUND AND USE IN OLIGONUCLEOTIDES”. With publication no. WO/2026/124677, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07H 19/167

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....